XML 32 R23.htm IDEA: XBRL DOCUMENT
v3.23.3

Accrued Liabilities (Notes) | 9 Months Ended
--- | ---
Sep. 30, 2023
Accrued Liabilities [Abstract] |
Accounts Payable and Accrued Liabilities Disclosure [Text Block] | Accrued Liabilities and Other Long-Term Liabilities Accrued liabilities consist of the following (in thousands):
| As of
| September 30, 2023 |  | December 31, 2022
Salaries and benefits | $ | 53,763 |  |  | $ | 44,304 |
Incentive compensation | 25,853 |  |  | 30,254 |
Operating lease liability-ST | 19,850 |  |  | 18,169 |
Accrued sales taxes | 6,440 |  |  | 5,844 |
Restructuring accrual | 4,335 |  |  | 5,923 |
Deferred revenue | 28,768 |  |  | 30,838 |
Accrued other taxes | 5,657 |  |  | 5,794 |
Accrued professional fees | 3,194 |  |  | 5,317 |
Italy medical device payback provision(1) | 22,754 |  |  | 7,900 |
Legal accrual | 1,601 |  |  | 3,137 |
Distribution fees | 12,500 |  |  | 17,063 |
Warranties and returns | 3,576 |  |  | 3,097 |
Field service corrective action(2) | 26,382 |  |  | 24,517 |
Accrued freight | 17,544 |  |  | 17,988 |
Foreign exchange contracts | 1,890 |  |  | 1,847 |
Accrued research and development | — |  |  | 3,538 |
Accrued audit fees | 6,362 |  |  | 6,279 |
Defined benefit plan | 2,064 |  |  | 2,928 |
Accrued interest | 1,083 |  |  | 1,033 |
Other | 7,708 |  |  | 6,999 |
| $ | 251,324 |  |  | $ | 242,769 |
___________________________ (1) As of December 31, 2022, there was $12.1 million in payback provision recorded as a reduction to accounts receivable, net. The Company reclassified such amount to accrued liabilities as of September 30, 2023. This amount was not reclassified as of December 31, 2022 to conform to the current year presentation. (2) Relates to field service corrective actions associated with certain products in connection with a 2021 Warning Letter received by Smiths Medical from the FDA following an inspection of Smiths Medical’s Oakdale, Minnesota Facility, see Note 19: Commitments and Contingencies for further detail. Other long-term liabilities consist of the following (in thousands):
| As of
| September 30, 2023 |  | December 31, 2022
Operating lease liability-LT | $ | 57,277 |  |  | $ | 60,916 |
Benefits | 4,999 |  |  | 5,314 |
Accrued rent | 864 |  |  | 997 |
Finance lease liability-LT | 2,018 |  |  | 1,855 |
Deferred revenue | 11,836 |  |  | 16,239 |
Field service corrective action(1) | 19,470 |  |  | 25,294 |
Other | 3,541 |  |  | 3,489 |
| $ | 100,005 |  |  | $ | 114,104 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration